Table 1.
Age-standardised cases of tuberculosis, drug-susceptible tuberculosis, multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis among HIV-negative individuals in Nigeria, 2000–2016
| Prevalence | Incidence | |||||
|---|---|---|---|---|---|---|
| 2000 | 2016 | % change, 2000–2016 | 2000 | 2016 | % change, 2000–2016 | |
| Rate/100,000 (95% UI) | Rate/100,000 (95% UI) | Rate/100,000 (95% UI) | Rate/100,000 (95% UI) | |||
| Tuberculosis | 37,964.1 (32,963.3–43,057.0) | 31,643.5 (27,316.3–36,249.3) | −20.0% | 373.9 (300.2–455.4) | 199.2 (162.0–238.5) | −87.6% |
| Drug-susceptible tuberculosis | 269.9 (217.2–329.6) | 147.3 (119.4–180.2) | −83.3% | 362.8 (292.3–442.1) | 192.9 (157.3–231.8) | −88.0% |
| Multidrug-resistant tuberculosis | 8.2 (2.7–18.5) | 4.8 (2.0–9.5) | −72.5% | 11.1 (3.8–25.2) | 6.3 (2.7–12.8) | −76.6% |
| Latent tuberculosis infection | 37,685.9 (32,701.1–42,774.3) | 31,491.4 (27,161.1–36,074.3) | −19.7% | – | – | – |
| Deaths | DALYs | |||||
| Tuberculosis | 131.3 (101.7–177.9) | 45.0 (35.2–59.3) | −191.6% | 3524.8 (2696.8–4867.8) | 1159.3 (897.4–1557.6) | −204.1% |
| Drug-susceptible tuberculosis | 120.0 (92.0–163.4) | 40.9 (31.6–54.2) | −193.2% | 3228.3 (2414.1–4569.2) | 1056.5 (808.5–1427.6) | −205.6% |
| Multidrug-resistant tuberculosis | 11.3 (3.8–25.0) | 4.0 (1.7–7.9) | −179.1% | 295.7 (98.2–640.7) | 101.1 (43.0–199.7) | − 192.5% |
| Extensively drug-resistant tuberculosis | – | – | – | 0.9 (0.3–1.9) | 1.7 (0.7–3.4) | 48.1% |
- indicate less than one per 100,000 population